Search

everythinglearnresearchcommunity

for

Search:↓

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

Active oxygen scavengers can reverse the suppression of hair cell growth caused by androgens.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

P311 helps skin stem cells become myofibroblast-like cells, aiding wound healing.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

Eplerenone, a mineralocorticoid receptor antagonist, was found to promote hair growth in human hair follicles.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.